Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to antibody or antibody fragment or immunoglobulin;...
Reexamination Certificate
2007-04-10
2007-04-10
Hartley, Michael G. (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to antibody or antibody fragment or immunoglobulin;...
C424S001570, C424S001690, C424S178100
Reexamination Certificate
active
10086637
ABSTRACT:
Methods are provided for close-range intraoperative, endoscopic and intravascular detection and treatment of lesions, including tumors and non-malignant lesions. The methods use antibody fragments or subfragments labeled with isotopic and non-isotopic agents. Also provided are methods for detection and treatment of lesions with photodynamic agents and methods of treating lesions with a protein conjugated to an agent capable of being activated to emit Auger electron or other ionizing radiation. Compositions and kits useful in the above methods are also provided.
REFERENCES:
patent: 4331647 (1982-05-01), Goldenberg
patent: 4348376 (1982-09-01), Goldenberg
patent: 4361544 (1982-11-01), Goldenberg
patent: 4444744 (1984-04-01), Goldenberg
patent: 4460561 (1984-07-01), Goldenberg
patent: 4474893 (1984-10-01), Reading
patent: 4624846 (1986-11-01), Goldenberg
patent: 4706652 (1987-11-01), Horowitz
patent: 4782840 (1988-11-01), Martin, Jr. et al.
patent: 4818709 (1989-04-01), Primus et al.
patent: 4859449 (1989-08-01), Mattes
patent: 4932412 (1990-06-01), Goldenberg
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5057313 (1991-10-01), Shih et al.
patent: 5256395 (1993-10-01), Barbet et al.
patent: 5274076 (1993-12-01), Barbet et al.
Aitken et al., “A Gamma-Detecting Probe for Radioimmune Detection of CEA- Producing Tumors,”Diseases of the Colon&Rectumvol. 27, No. 5, (1984), pp. 279-282, American Society.
Allen et al., “Combined Laser Therapy and Endobronchial Radiotherapy for Unresectable Lung Carcinoma With Bronchial Obstruction,”American Journal of Surgeryvol. 150, (1985), pp. 71-77.
Better et al., “Escherichia coliSecretion of an Active Chimeric Antibody Fragment,”Sciencevol. 240, (1988), pp. 1041-1042.
Carter et al., “High LevelEscherichia coliExpression and Production of a Bivalent Humanized Antibody Fragment,”Biotechnologyvol. 10, (1992), pp. 163-167.
Fleischer, “Endoscopic Laser Therapy for Gastrointestinal Disease,”Acrh. Intern. Med.vol. 144, No. 6, (1984), pp. 1225-1230.
Hirano et al., “Photodynamic Cancer Diagnosis and Treatment System Consisting of Pulse Lasers and Endoscopic Spectro-Image Analyzer,”Lasers in the Life Sciencesvol. 3, No. 2, (1989), pp. 89-116.
Hunter et al., “Lasers in Endoscopic Gastrointestinal Surgery,”The American Journal of Surgery, vol. 148, (1984), pp. 736-741.
Krishnan et al., “Chimerization of Mu-9: A Colon-Specific Antigen-p Antibody Reactive with Gastrointestinal Carcinomas,”Cancer, vol. 80, No. 12, (1987), pp. 2667-2674.
Leung et al., “Bacterial Expression of Kemptide Fusion Protein Facilities32P labeling of a Humanized, Anti- Carcinoembryonic Antigen (hMN-14) Antibody Fragment,”Cancer Research, vol. 55, No. 23, (1995), pp. 5968-5972.
Milstein et al., “Hybrid Hybridomas and the Production of Bi-Specific Monoclonal Antibodies,”Immunology Today, vol. 5 No. 10, (1984), pp. 299-304.
Paganelli et al., “Three-Stop Monoclonal Antibody Tumor Targeting in Carcinoembyronic Antigen Positive Patients,”Cancer Research, vol. 51, No. 21, (1991), pp. 5960-5966.
Profio et al., “Flourescence Diagnosis of Cancer,”,Advances in Experimental Medicine and Biology, vol. 193, pp. 43-50, 1985.
Schray et al., “Management of Malignant Airway Obstruction: Clinical and Dosimetric Considerations Using An Iridium-192 Afterloading Technique in Conjunction with the Neodymium-Yag Laser,”Int. J. Radiation Oncology Biol. Phys., vol. 11, No. 2, (1985), pp. 403-409.
Scerra et al., “Assembly of a Functional Immunoglobulin FvFragment inEscherichia coli,” Science, vol. 240, (1988), pp. 1038-1041.
Studier et al., “Use of Bacteriophage T7 RNA Polymerase to Direct Selective High-Level Expression of Cloned Genes,”J. Mol. Biol., vol. 189, No. 1, (1986), pp. 113-130.
Tatsuta et al., “Diagnosis of Gastric Cancers With Flourescein- Labeled Monoclonal Antibodies to Carcinoembryonic Antigen,”Lasers in Surgery and Medicine, vol. 9, No. 4, (1989).
Wood et al., “Tumor Ablation by Endoscopic Nd: YAG Laser,”The American Journal of Gastroenterology, vol. 80, No. 9 (1985), pp. 715-718.
Profio, “Review of Flourescence Diagnosis Using Porphyrins,” SPIE—The International Society For Optical Engineering, vol. 907, (1988), pp. 150-156.
Paganelli et al., “Monoclonal Antibody Pretargeting Techniques for Tumour Localization: The Avidin-Biotin System,”Nuclear Medicine Communications, vol. 12, (1991), pp. 211-234.
Pelegrin et al., “Antibody-Flourescein Conjugates for Photoimmunodiagnosis of Human Colon Carcinoma in Nude Mice,”Cancer, vol. 67, (1991), pp. 2529-2537.
Van Den Bergh, “Lighy and Porphyrins in Cancer Therapy,”Chem., Britain, vol. 22, (1986), pp. 430-439.
Dougherty et al., “Photoradiation Therapy for the Treatment of Malignant Tumors,”Cancer Research, vol. 38, (1978), pp. 2628-2635.
Dougherty et al., “Photosensitizers: Therapy and Detection of Malignant Tumors,”Photochem and Photobiology, vol. 45, No. 6, (1987), pp. 879-889.
Doiron et al., “Flourescence Bronchoscopy for Detection of Lung Cancer,”Chest, vol. 76, No. 1, (1979), pp. 27-32.
Mew et al., “Photoimmunotherapy: Treatment of Animal Tumors with Tumor-Specific Monocional Antibody-Hematoporphyrin Conjugates,”Journal of Immunology, vol. 130, No. 3, (1983), pp. 1473-1477.
Mew et al., “Ability of Specific Monoclonal Antibodies and Conventional Antisera Conjugated to Hematoporphyrin to Label and Kill Selected Cell Lines Subsequent to Light Activation,”Cancer Research, vol. 45, (1985), pp. 4380-4386.
Oseroff et al., “Antibody- Targeted Photolysis: Selective Photodestruction of Human T-Cell Leukemia Cells Using Monoclonal Antibody-Chlorin θ6Conjugates,”Proc. Natl. Acad. Sci.USA, vol. 83, (1986), pp. 8744-8748.
Oseroff et al., “Strategies for Selective Cancer Photochemotherapy: Antibody- Targeted and Selective Carcinoma Cell Photolysis,”Photochemistry and Photobiology, vol. 46, No. 1, (1987), pp. 83-96.
Hasan et al., “Laser-Induced Selective Cytotoxicity Using Monoclonal Antibody-Chromophore Conjugates,”Immunity to Cancer, vol. II, (1989), pp. 471-477.
Adams et al., “Highly Specificin VivoTumor Targeting by Monovalent and Divalent Forms of 741F8 Anti-c-erbB-2 Single-Chain Fv,”Cancer Research, vol. 53, (1993), pp. 4026-4034.
Haunschild et al., “Pharmacokinetic Properties of Bivalant Miniantibodies and Comparison to Other Immunoglobulin Forms,”Antibody, Immunoconjugates and Radiopharmaceuticals, vol. 8, No. 2, (1995), pp. 111-128.
Tai et al., “Targeting c-erB-2 Expressing Tumors Using Single-Chain FV Monomers and Dimers,”Cancer Research, vol. 55, (1995), pp. 5983-5989.
Faegre & Benson LLP
Hartley Michael G.
Immunomedics Inc.
LandOfFree
Intraoperative, intravascular and endoscopic tumor and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intraoperative, intravascular and endoscopic tumor and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraoperative, intravascular and endoscopic tumor and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3789134